https://www.selleckchem.com/pr....oducts/GSK690693.htm
We review recently published trial evidence and propose important future directions to improve upon our understanding of these relationships.Acute kidney injury (AKI) is common among hospitalized patients with coronavirus disease 2019 (COVID-19), with the occurrence of AKI ranging from 0.5% to 80%. An improved knowledge of the pathology of AKI in COVID-19 is crucial to mitigate and manage AKI and to improve the survival of patients who develop AKI during COVID-19. In this review, we summarize the published cases and case series of var
Like
Comment
Share
